MOS
50
4
URI
45
-4
CNX
76
5
CLX
65
-4
FOXA
57
-2
BXP
49
-3
VMC
51
3
AVB
57
2
ABBV
40
-2
GIS
34
-3
WY
48
-2
JCI
51
4
EMC
77
6
CINF
31
2
DD
55
2
NRG
40
3
TDC
86
2
GME
57
5
HSY
38
-7
GPC
37
-3
MOS
50
4
URI
45
-4
CNX
76
5
CLX
65
-4
FOXA
57
-2
BXP
49
-3
VMC
51
3
AVB
57
2
ABBV
40
-2
GIS
34
-3
WY
48
-2
JCI
51
4
EMC
77
6
CINF
31
2
DD
55
2
NRG
40
3
TDC
86
2
GME
57
5
HSY
38
-7
GPC
37
-3
Financhill
Back

Neuberger Brmn Nxt Gnrtn Cnnctd Cnsm ETF Vs. Aligos Therapeutics Industry Stock Comparison

Buy
88

NBCC
Neuberger Brmn Nxt Gnrtn Cnnctd Cnsm ETF

Last Price:
25.98
Seasonality Move:
5.71%
Buy
75

ALGS
Aligos Therapeutics

Last Price:
33.28
Seasonality Move:
10.65%
Buy
88
Neuberger Brmn Nxt Gnrtn Cnnctd Cnsm ETF (NBCC) is a Buy

Is Neuberger Brmn Nxt Gnrtn Cnnctd Cnsm ETF a Buy, Sell or Hold?

  • The current Neuberger Brmn Nxt Gnrtn Cnnctd Cnsm ETF [NBCC] share price is $25.76. The Score for NBCC is 88, which is 76% above its historic median score of 50, and infers lower risk than normal.
  • NBCC is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
75
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NBCC Stock Price Chart

What is Neuberger Brmn Nxt Gnrtn Cnnctd Cnsm ETF's stock price today?

  • The Neuberger Brmn Nxt Gnrtn Cnnctd Cnsm ETF share price today is $25.76
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBCC is experiencing slight buying pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $34.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

NBCC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.38 Buy
Relative Strength Index (14 RSI): 88.52 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.36 - 25.38) Buy
Bollinger Bands (100): (22.7 - 24.68) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.71 Buy
Relative Strength Index (14 RSI): 85.17 Buy
Chaikin Money Flow: 491004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.08 - 27.66) Buy
Bollinger Bands (100): (7.67 - 19.61) Buy

NBCC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.5 Buy
20-day SMA: 25 Buy
50-day SMA: 24.48 Buy
200-day SMA: 23.28 Buy
8-day EMA: 25.5 Buy
20-day EMA: 25.11 Buy
50-day EMA: 24.54 Buy
200-day EMA: 23.38 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.48 Buy
20-day SMA: 23.64 Buy
50-day SMA: 14.76 Buy
200-day SMA: 15.86 Buy
8-day EMA: 28.77 Buy
20-day EMA: 23.99 Buy
50-day EMA: 18.16 Buy
200-day EMA: 16.13 Buy

Neuberger Brmn Nxt Gnrtn Cnnctd Cnsm ETF Earnings Growth & NBCC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Neuberger Brmn Nxt Gnrtn Cnnctd Cnsm ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):